Asthma & COPD Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

Report Summary

Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Asthma & COPD market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.

Asthma & COPD market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

To learn more about this report

Request For Sample

Key Research Highlights: Market Drivers

The Asthma & COPD market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Asthma & COPD products across developed and developing countries of the world.

Key Research Highlights: Market Restrains

Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Asthma & COPD products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Asthma & COPD market.

To learn more about this report

Request For Sample

Key Research Highlights: Trends

Increasing research and development spending on Asthma & COPD development has been the leading industry trend of Asthma & COPD market

The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.

Global Asthma & COPD Market Size, 2018-2028 (USD MILLION)

To learn more about this report

Request For Sample

Market Segmentation

Report Attributes	Details
The market size value in 2021	USD XX.XX Million
CAGR (2021 - 2028)	XX.XX %
The Revenue forecast in 2028	USD XX.XX Million
Base year for estimation	2021
Historical data	2018-2019
Forecast period	2022-2028
Quantitative units	Revenue in USD Million CAGR from 2021 to 2028
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook	Anti-inflammatory Drugs, Bronchodilator Monotherapy, Combination Drugs, Other
By Application Outlook	Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope	U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled	GSK, Novartis, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer, Mylan, Allergan, Cipla, Akorn
Customization Available	Yes, the report can be tailored to meet your specific requirements.

Key Market Players

• GSK
• Novartis
• Merck
• Abbott
• Boehringer Ingelheim
• AstraZeneca
• Roche
• Teva
• Vectura
• Pfizer
• Mylan
• Allergan
• Cipla
• Akorn

Asthma & COPD Market, By Type

• Anti-inflammatory Drugs
• Bronchodilator Monotherapy
• Combination Drugs
• Other

Asthma & COPD Market, By Application

• Hospital Pharmacies
• Private Clinics
• Drug Stores
• Retail Pharmacies
• E-Commerce

Key Benefits To The Stake Holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Table Of Contents

Table of Contents

1 Study Coverage
1.1 Asthma & COPD Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Asthma & COPD Market Size Growth Rate by Product
1.4.2 Anti-inflammatory Drugs
1.4.3 Bronchodilator Monotherapy
1.4.4 Combination Drugs
1.5 Market by End User
1.5.1 Global Asthma & COPD Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Drug Stores
1.5.5 Retail Pharmacies
1.5.6 E-Commerce
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Asthma & COPD Market Size
2.1.1 Global Asthma & COPD Revenue 2017-2027
2.1.2 Global Asthma & COPD Sales 2017-2027
2.2 Asthma & COPD Growth Rate by Regions
2.2.1 Global Asthma & COPD Sales by Regions
2.2.2 Global Asthma & COPD Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Asthma & COPD Sales by Manufacturers
3.1.1 Asthma & COPD Sales by Manufacturers
3.1.2 Asthma & COPD Sales Market Share by Manufacturers
3.1.3 Global Asthma & COPD Market Concentration Ratio (CR5 and HHI)
3.2 Asthma & COPD Revenue by Manufacturers
3.2.1 Asthma & COPD Revenue by Manufacturers (2017-2020)
3.2.2 Asthma & COPD Revenue Share by Manufacturers (2017-2020)
3.3 Asthma & COPD Price by Manufacturers
3.4 Asthma & COPD Manufacturing Base Distribution, Product Types
3.4.1 Asthma & COPD Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma & COPD Product Type
3.4.3 Date of International Manufacturers Enter into Asthma & COPD Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Asthma & COPD Sales by Product
4.2 Global Asthma & COPD Revenue by Product
4.3 Asthma & COPD Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Asthma & COPD Breakdown Data by End User

6 North America
6.1 North America Asthma & COPD by Countries
6.1.1 North America Asthma & COPD Sales by Countries
6.1.2 North America Asthma & COPD Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Asthma & COPD by Product
6.3 North America Asthma & COPD by End User

7 Europe
7.1 Europe Asthma & COPD by Countries
7.1.1 Europe Asthma & COPD Sales by Countries
7.1.2 Europe Asthma & COPD Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma & COPD by Product
7.3 Europe Asthma & COPD by End User

8 Asia Pacific
8.1 Asia Pacific Asthma & COPD by Countries
8.1.1 Asia Pacific Asthma & COPD Sales by Countries
8.1.2 Asia Pacific Asthma & COPD Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Asthma & COPD by Product
8.3 Asia Pacific Asthma & COPD by End User

9 Central & South America
9.1 Central & South America Asthma & COPD by Countries
9.1.1 Central & South America Asthma & COPD Sales by Countries
9.1.2 Central & South America Asthma & COPD Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Asthma & COPD by Product
9.3 Central & South America Asthma & COPD by End User

10 Middle East and Africa
10.1 Middle East and Africa Asthma & COPD by Countries
10.1.1 Middle East and Africa Asthma & COPD Sales by Countries
10.1.2 Middle East and Africa Asthma & COPD Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Asthma & COPD by Product
10.3 Middle East and Africa Asthma & COPD by End User

11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.1.4 GSK Asthma & COPD Products Offered
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Novartis Asthma & COPD Products Offered
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Merck Asthma & COPD Products Offered
11.3.5 Merck Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Abbott Asthma & COPD Products Offered
11.4.5 Abbott Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Boehringer Ingelheim Asthma & COPD Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZeneca Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.6.4 AstraZeneca Asthma & COPD Products Offered
11.6.5 AstraZeneca Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Company Business Overview
11.7.3 Roche Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Roche Asthma & COPD Products Offered
11.7.5 Roche Recent Development
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Company Business Overview
11.8.3 Teva Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Teva Asthma & COPD Products Offered
11.8.5 Teva Recent Development
11.9 Vectura
11.9.1 Vectura Company Details
11.9.2 Company Business Overview
11.9.3 Vectura Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Vectura Asthma & COPD Products Offered
11.9.5 Vectura Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Business Overview
11.10.3 Pfizer Asthma & COPD Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Pfizer Asthma & COPD Products Offered
11.10.5 Pfizer Recent Development
11.11 Mylan
11.12 Allergan
11.13 Cipla
11.14 Akorn

12 Future Forecast
12.1 Asthma & COPD Market Forecast by Regions
12.1.1 Global Asthma & COPD Sales Forecast by Regions 2021-2027
12.1.2 Global Asthma & COPD Revenue Forecast by Regions 2021-2027
12.2 Asthma & COPD Market Forecast by Product
12.2.1 Global Asthma & COPD Sales Forecast by Product 2021-2027
12.2.2 Global Asthma & COPD Revenue Forecast by Product 2021-2027
12.3 Asthma & COPD Market Forecast by End User
12.4 North America Asthma & COPD Forecast
12.5 Europe Asthma & COPD Forecast
12.6 Asia Pacific Asthma & COPD Forecast
12.7 Central & South America Asthma & COPD Forecast
12.8 Middle East and Africa Asthma & COPD Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma & COPD Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer